Portal Biotech

@PortalBiotech Closes $35M Series A to Deliver World's First Full-Length Single-Molecule protein Sequencer. Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development & diagnostics #proteomics #nanopore

New preprint from us, as #JPM2026 kicks off: collaboration with Giovanni Maglia’s group in Groningen and researchers at ETH Zürich: lnkd.in/ehzPq4WE This is the first generalisable nanopore system capable of reading full-length proteins; a leap towards protein sequencing!

𝗙𝘂𝗹𝗹 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 > bit.ly/406Wado

𝗧𝗵𝗲 𝗽𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻: 𝗮 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗔𝗻𝗱𝘆 𝗛𝗲𝗿𝗼𝗻 𝗮𝗯𝗼𝘂𝘁 𝗣𝗼𝗿𝘁𝗮𝗹’𝘀 𝗰𝗼𝗿𝗲 𝘁𝗲𝗰𝗵 Delve into why this breakthrough could define a new era in biotech, drug discovery and precision medicine (full article below).